Medical device and MedTech insights, news, tips and more

Vicarious Surgical Wins FDA Breakthrough Designation for Surgical Robot

December 9, 2019

Vicarious Surgical - Surgeon

Vicarious Surgical Inc., the leading innovator in virtual reality and robotics for minimally invasive surgical treatments, announced today they were recently granted the Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

The FDA Breakthrough Devices Program is intended to help patients receive more timely access to breakthrough technologies that have the potential to provide more effective treatment. Under the program, the FDA provides priority review and interactive communication regarding device development and clinical trial protocols, through to commercialization decisions.

“We are the first surgical robot to be recognized with the FDA’s Breakthrough classification,” says Adam Sachs, CEO and Co-Founder of Vicarious Surgical. “This validates the platform we are developing and the clinical value it can offer surgeons and patients. It also adds to our momentum as we advance our innovative technology toward commercialization.”

Additionally, Vicarious Surgical has appointed Scott Huennekens, a proven leader in the medical device industry, to its Board of Directors. He most recently served as the President & CEO of Verb Surgical, a Google and J&J joint venture, and was previously President & CEO at Volcano Therapeutics and Digirad Corporation. Mr. Huennekens holds an MBA from Harvard University and a B.S. in business administration from the University of Southern California.

Mr. Sachs states, “Scott has keen business insight into the complex surgical robotics market and brings a wealth of experience from the broader medical device industry. Vicarious Surgical will benefit greatly from his involvement as we continue with fundraising, product development and organizational growth. We are thrilled to have Scott join our Board of Directors.”

“I am honored to join Vicarious Surgical’s Board of Directors,” says Mr. Huennekens. “Vicarious Surgical has developed the most innovative robotic technology I have seen, and I believe it will transform the future of minimally invasive surgery.”

See Full Press Release: Vicarious Surgical Announces Breakthrough Designation by the FDA, Appoints Scott Huennekens to Board of Directors


Written by: Vicarious Surgical


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

November 11, 2024
What is the Difference Between MedTech and TechMed?  
Learn More
March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.